Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook When Pfizer research scientist Jim Mobley was asked to switch his research focus from asthma to ...

Immunologist Johan Van Weyenbergh (KU Leuven) and his Belgian-Brazilian colleagues have shown that a drug used to fight arthritis also stops the process that allows the tuberculosis bacillus to infect ...

Immunologist Johan Van Weyenbergh (KU Leuven) and his Belgian-Brazilian colleagues have shown that a drug used to fight arthritis also stops the process that allows the tuberculosis bacillus to infect ...

July 10 -- THURSDAY, July 9 (HealthDay News) -- An arthritis therapy appears to increase the risk of tuberculosis in certain patients, French researchers have found. Their study examined the ...

The U.S. Centers for Disease Control and Prevention has awarded Case Western Reserve University School of Medicine a 10-year, $19.7 million contract as an international clinical trials site for the ...

We are at a critical time and supporting climate journalism is more important than ever. Science News and our parent organization, the Society for Science, need your help to strengthen environmental ...

THIS report deals with 92 cases of extrapulmonary tuberculosis treated with streptomycin in various amounts and over different lengths of time. In all cases the lesions were proved to be tuberculous ...

The purified-protein-derivative (PPD)-based tuberculin skin test (TST) that is most commonly used to detect latent tuberculosis infection is dependent on normal T-cell function. Patients with ...

Immunologists have shown that a drug used to fight arthritis also stops the process that allows the tuberculosis bacillus to infect and hijack blood stem cells. Immunologist Johan Van Weyenbergh (KU ...